If you are wondering whether Amgen stock still offers value at current levels, this article walks through what the numbers ...
A U.S. Centers for Medicare & Medicaid Services 18-month trial program will offer for the first time Novo Nordisk’s Wegovy ...
Alphabet may be the Dow's newest member, but these three dividend-paying Dow stocks look like the better buys for income ...
Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...
By Puyaan Singh June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical ...
A clinical trial used to approve Amgen Inc.’s pill Tavneos was retracted Monday from the New England Journal of Medicine, ...
Zacks Investment Research on MSN
Investors heavily search Amgen Inc. (AMGN): Here is what you need to know
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...
Amgen has recalled select lots of its heart medication Corlanor and kidney disease treatment Sensipar because of foreign material concerns and current good manufacturing practice deviations. The ...
Roche’s investigational KRAS G12C inhibitor has beaten Amgen’s Lumakras and Bristol Myers Squibb’s Krazati in a phase 3 trial ...
StockStory.org on MSN
Amgen (AMGN) stock is up, what you need to know
What Happened? Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results